Yes, combining a biologic DMARD like Rinvoq (Upadacitinib) with a conventional DMARD such as Leflunomide is a common strategy to manage rheumatoid arthritis (RA) more effectively. This approach can help in controlling symptoms and slowing disease progression by targeting different aspects of the immune system. However, it's Show Full Answer

Yes, combining a biologic DMARD like Rinvoq (Upadacitinib) with a conventional DMARD such as Leflunomide is a common strategy to manage rheumatoid arthritis (RA) more effectively. This approach can help in controlling symptoms and slowing disease progression by targeting different aspects of the immune system. However, it's important to monitor for any potential side effects and interactions. Always discuss any concerns or unusual symptoms with your RA doctor to ensure the best care tailored to your condition.

 This AI-generated response comes from myRAteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Combining 2 Biologic Drugs for RA Increases Serious Side Effects — and Doesn’t Appear to Improve Symptoms

Rheumatoid Arthritis vs. Lupus: What's the Difference? | myRAteam